Shmagin Martin E 4
4 · Urigen Pharmaceuticals, Inc. · Filed Mar 10, 2009
Insider Transaction Report
Form 4
Urigen Pharmaceuticals, Inc.UGRP.OB
Shmagin Martin E
DirectorChief Financial Officer
Transactions
- Purchase
Common Stock, $.001 Par Value
2009-03-06$0.08/sh+1,000$80→ 3,131,073 total - Purchase
Common Stock, $.001 Par Value
2009-03-05$0.08/sh+4,000$320→ 3,130,073 total